Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil R Birkett

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Angewandte Chemie (International Ed. in English)|June 30, 2009
Long-range correlations between aliphatic 13C nuclei in protein MAS NMR spectroscopyMarvin J Bayro, Thorsten Maly, Neil R Birkett, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2008
Direct characterization of amyloidogenic oligomers by single-molecule fluorescenceAngel Orte, Neil R Birkett, Richard W Clarke, et al.
Biochemistry|August 17, 2010
High-resolution MAS NMR analysis of PI3-SH3 amyloid fibrils: backbone conformation and implications for protofilament assembly and structure Marvin J Bayro, Thorsten Maly, Neil R Birkett, et al.
Journal of the American Chemical Society|July 22, 2011
Intermolecular structure determination of amyloid fibrils with magic-angle spinning and dynamic nuclear polarization NMRMarvin J Bayro, Galia T Debelouchina, Matthew T Eddy, et al.
Chembiochem : a European Journal of Chemical Biology|May 6, 2009
Position-dependent electrostatic protection against protein aggregationAlexander K Buell, Gian Gaetano Tartaglia, Neil R Birkett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive TumorsSophie Archer, Phillip M Brailey, Minjung Song, et al.
British Journal of Cancer|December 31, 2021
The multi-specific V<sub>H</sub>-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activityCarolyn J Edwards, Angelica Sette, Carl Cox, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Angewandte Chemie (International Ed. in English)|June 30, 2009
Long-range correlations between aliphatic 13C nuclei in protein MAS NMR spectroscopyMarvin J Bayro, Thorsten Maly, Neil R Birkett, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2008
Direct characterization of amyloidogenic oligomers by single-molecule fluorescenceAngel Orte, Neil R Birkett, Richard W Clarke, et al.
Biochemistry|August 17, 2010
High-resolution MAS NMR analysis of PI3-SH3 amyloid fibrils: backbone conformation and implications for protofilament assembly and structure Marvin J Bayro, Thorsten Maly, Neil R Birkett, et al.
Journal of the American Chemical Society|July 22, 2011
Intermolecular structure determination of amyloid fibrils with magic-angle spinning and dynamic nuclear polarization NMRMarvin J Bayro, Galia T Debelouchina, Matthew T Eddy, et al.
Chembiochem : a European Journal of Chemical Biology|May 6, 2009
Position-dependent electrostatic protection against protein aggregationAlexander K Buell, Gian Gaetano Tartaglia, Neil R Birkett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive TumorsSophie Archer, Phillip M Brailey, Minjung Song, et al.
British Journal of Cancer|December 31, 2021
The multi-specific V<sub>H</sub>-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activityCarolyn J Edwards, Angelica Sette, Carl Cox, et al.
Pageof 1